Severe pulmonary toxicity in patients with leiomyosarcoma after treatment with gemcitabine and docetaxel
- 13 January 2007
- journal article
- case report
- Published by Springer Nature in Investigational New Drugs
- Vol. 25 (3) , 279-281
- https://doi.org/10.1007/s10637-006-9030-7
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Docetaxel and gemcitabine combination in 133 advanced soft‐tissue sarcomas: A retrospective analysisInternational Journal of Cancer, 2006
- Clinical features and correlates of gemcitabine‐associated lung injuryCancer, 2006
- SCOTROC 2A: Carboplatin followed by docetaxel or docetaxel–gemcitabine as first-line chemotherapy for ovarian cancerBritish Journal of Cancer, 2006
- High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patients with non-small cell lung cancer: results of a dose-finding studyLung Cancer, 2004
- Laboratory and Clinical Evidence of Synergistic Cytotoxicity of Sequential Treament With Gemcitabine Followed by Docetaxel in the Treatment of SarcomaJournal of Clinical Oncology, 2004
- Gemcitabine and Docetaxel in Patients With Unresectable Leiomyosarcoma: Results of a Phase II TrialJournal of Clinical Oncology, 2002